Role of IL-6/IL-10 ratio in the diagnosis and in the assessment of the severity of obsessive-compulsive disorder
- 4 Downloads
Obsessive-compulsive disorder (OCD) has a genetic and environmental pathogenesis. The immunologic changes in OCD have been proven in many studies, but those tackling cytokine in OCD are still limited. The present study aims to evaluate the diagnostic performance of IL-6, IL-10, and the IL-6/IL-10 ratio in the OCD patient group, and to show their correlation with the clinical parameters of OCD. Eighty subjects (60 OCD patients and 20 matched controls) were participating in this study. The enzyme-linked immunosorbent assay was run to quantify the IL-6 and IL-10. Serum IL-6 exhibited a higher result in OCD patients than controls (p = 0.002) but serum IL-10 levels had no significant difference (p > 0.05). IL-6/IL-10 ratio showed significantly higher values in OCD patients than controls (p < 0.0001). Serum IL-6 and IL-6/IL-10 ratio were negatively correlated with age of onset but were directly correlated with disease duration and disease severity. IL-6/IL-10 ratio showed 86.7% sensitivity and 90% specificity in OCD diagnosis. An immune activation is implicated in the OCD pathogenesis. This was confirmed by the high serum levels of IL-6 in OCD patients. IL-6/IL-10 ratio showed a considerable sensitivity and specificity in the OCD diagnosis. IL-6 and IL-6/IL-10 ratio are correlated positively with the OCD intensity.
KeywordsCytokine Interleukin-6, interleukin-10 OCD
Area under the curve
Enzyme-linked immunosorbent assay
Negative predictive value
Positive predictive value
Receiver operating characteristic
Yale Brown Obsessive-Compulsive Scale
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
All procedures performed in the study involving human participants were in accordance with the ethical standards of the Ethical Committee of the Faculty of Human Medicine, Zagazig University.
All study subjects were requested to participate, and they gave written informed consent.
- Aouizerate B, Guehl D, Cuny E, Rougier A, Bioulac B, Tignol J, Burbaud P (2004) Pathophysiology of obsessive-compulsive disorder: a necessary link between phenomenology, neuropsychology, imagery and physiology. Prog Neurobiol 72:195–221. https://doi.org/10.1016/j.pneurobio.2004.02.004 CrossRefPubMedGoogle Scholar
- Elenkov IJ, Chrousos GP (2002) Stress hormones, proinflammatory and antiinflammatory cytokines, and autoimmunity. Ann N Y Acad Sci 966:290–303. https://doi.org/10.1111/j.1749-6632.2002.tb04229.x CrossRefPubMedGoogle Scholar
- Felger JC, Li L, Marvar PJ, Woolwine BJ, Harrison DG, Raison CL, Miller AH (2013) Tyrosine metabolism during interferon-alpha administration: association with fatigue and CSF dopamine concentrations. Brain Behav Immun 31:153–160. https://doi.org/10.1016/j.bbi.2012.10.010 CrossRefPubMedGoogle Scholar
- Fluitman S, Denys D, Vulink N, Schutters S, Heijnen C, Westenberg H (2010) Lipopolysaccharide-induced cytokine production in obsessive-compulsive disorder and generalized social anxiety disorder. Psychiatry Res 178(2):313–316. https://doi.org/10.1016/j.psychres.2009.05.008 CrossRefPubMedGoogle Scholar
- Goodman WK, Price LH, Rasmussen SA, Mazure C, Delgado P, Heninger GR, Charney DS (1989) The Yale-Brown obsessive compulsive scale. II Validity. Arch Gen Psychiatry 46(11):1012–1016. https://doi.org/10.1001/archpsyc.1989.01810110054008 CrossRefPubMedGoogle Scholar
- Koenig MK, Butler IJ (2011) Tetrahydrobiopterin deficiency. In: Gadoth N, Göbel H (eds) Oxidative stress and free radical damage in neurology. Oxidative stress in applied basic research and clinical practice. Humana Press, New York City, pp 225–234. https://doi.org/10.1007/978-1-60327-514-9_13 CrossRefGoogle Scholar
- Maina G, Pessina E, Albert U, Bogetto F (2008) 8-week single-blind, randomized trial comparing risperidone versus olanzapine augmentation of serotonin reuptake inhibitors in treatment resistant obsessive–compulsive disorder. Eur Neuropsychopharmacol 18:364–372. https://doi.org/10.1016/j.euroneuro.2008.01.001 CrossRefPubMedGoogle Scholar
- Rodriguez CI, Kegeles LS, Levinson A, Ogden RT, Mao X, Milak MS, Vermes D, Xie S, Hunter L, Flood P (2015) In vivo effects of ketamine on glutamate-glutamine and gamma-aminobutyric acid in obsessive -compulsive disorder: proof of concept. Psychiatry Res Neuroimaging 233:141–147. https://doi.org/10.1016/j.pscychresns.2015.06.001 CrossRefGoogle Scholar
- Russell A, Cortese B, Lorch E, Ivey J, Banerjee SP, Moore GJ, Rosenberg DR (2003) Localized functional neurochemical marker abnormalities in dorsolateral prefrontal cortex in pediatric obsessive-compulsive disorder. J Child Adolesc Psychopharmacol 13:31–38. https://doi.org/10.1089/104454603322126322 CrossRefGoogle Scholar